nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—SLC29A1—Fluorouracil—head and neck cancer	0.643	1	CbGbCtD
Ribavirin—NT5C2—Purine catabolism—GPX1—head and neck cancer	0.0104	0.136	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00632	0.0826	CbGpPWpGaD
Ribavirin—NT5C2—mouth—head and neck cancer	0.00532	0.0698	CbGeAlD
Ribavirin—NT5C2—neck—head and neck cancer	0.00455	0.0597	CbGeAlD
Ribavirin—ENPP1—connective tissue—head and neck cancer	0.00447	0.0585	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.0042	0.0549	CbGpPWpGaD
Ribavirin—NT5C2—Purine metabolism—GPX1—head and neck cancer	0.00401	0.0524	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—DPYD—head and neck cancer	0.00374	0.0488	CbGpPWpGaD
Ribavirin—NT5C2—parotid gland—head and neck cancer	0.00371	0.0486	CbGeAlD
Ribavirin—NT5C2—saliva-secreting gland—head and neck cancer	0.00355	0.0465	CbGeAlD
Ribavirin—SLC28A3—trachea—head and neck cancer	0.00329	0.0432	CbGeAlD
Ribavirin—IMPDH1—Purine metabolism—GPX1—head and neck cancer	0.00327	0.0427	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide metabolism—DPYD—head and neck cancer	0.00305	0.0398	CbGpPWpGaD
Ribavirin—ADK—Purine metabolism—GPX1—head and neck cancer	0.00304	0.0397	CbGpPWpGaD
Ribavirin—IMPDH1—parotid gland—head and neck cancer	0.00301	0.0395	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00299	0.039	CbGpPWpGaD
Ribavirin—ENPP1—thyroid gland—head and neck cancer	0.00297	0.0389	CbGeAlD
Ribavirin—IMPDH1—saliva-secreting gland—head and neck cancer	0.00288	0.0378	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—DPYD—head and neck cancer	0.00283	0.037	CbGpPWpGaD
Ribavirin—NT5C2—trachea—head and neck cancer	0.00274	0.0359	CbGeAlD
Ribavirin—ENPP1—head—head and neck cancer	0.00263	0.0345	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00239	0.0313	CbGpPWpGaD
Ribavirin—NT5C2—lymphoid tissue—head and neck cancer	0.00239	0.0313	CbGeAlD
Ribavirin—ADK—parotid gland—head and neck cancer	0.00237	0.0311	CbGeAlD
Ribavirin—ADK—saliva-secreting gland—head and neck cancer	0.00227	0.0298	CbGeAlD
Ribavirin—IMPDH1—trachea—head and neck cancer	0.00222	0.0291	CbGeAlD
Ribavirin—NT5C2—thyroid gland—head and neck cancer	0.00217	0.0284	CbGeAlD
Ribavirin—NT5C2—Nucleotide metabolism—TYMS—head and neck cancer	0.00213	0.0278	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—GPX1—head and neck cancer	0.00202	0.0263	CbGpPWpGaD
Ribavirin—IMPDH1—lymphoid tissue—head and neck cancer	0.00194	0.0254	CbGeAlD
Ribavirin—NT5C2—head—head and neck cancer	0.00192	0.0252	CbGeAlD
Ribavirin—ENPP1—lymph node—head and neck cancer	0.00184	0.0242	CbGeAlD
Ribavirin—SLC29A1—connective tissue—head and neck cancer	0.00178	0.0233	CbGeAlD
Ribavirin—IMPDH1—thyroid gland—head and neck cancer	0.00176	0.0231	CbGeAlD
Ribavirin—ADK—trachea—head and neck cancer	0.00175	0.023	CbGeAlD
Ribavirin—IMPDH1—Nucleotide metabolism—TYMS—head and neck cancer	0.00174	0.0227	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide metabolism—GPX1—head and neck cancer	0.00164	0.0215	CbGpPWpGaD
Ribavirin—ADK—Nucleotide metabolism—TYMS—head and neck cancer	0.00161	0.0211	CbGpPWpGaD
Ribavirin—IMPDH1—head—head and neck cancer	0.00156	0.0205	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—GPX1—head and neck cancer	0.00153	0.0199	CbGpPWpGaD
Ribavirin—ADK—lymphoid tissue—head and neck cancer	0.00153	0.02	CbGeAlD
Ribavirin—SLC29A1—trachea—head and neck cancer	0.00149	0.0196	CbGeAlD
Ribavirin—ADK—thyroid gland—head and neck cancer	0.00139	0.0182	CbGeAlD
Ribavirin—NT5C2—lymph node—head and neck cancer	0.00135	0.0176	CbGeAlD
Ribavirin—SLC29A1—lymphoid tissue—head and neck cancer	0.0013	0.017	CbGeAlD
Ribavirin—ADK—head—head and neck cancer	0.00123	0.0161	CbGeAlD
Ribavirin—SLC29A1—thyroid gland—head and neck cancer	0.00118	0.0155	CbGeAlD
Ribavirin—ENPP1—Endochondral Ossification—VEGFA—head and neck cancer	0.00109	0.0143	CbGpPWpGaD
Ribavirin—IMPDH1—lymph node—head and neck cancer	0.00109	0.0143	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.00109	0.0142	CbGpPWpGaD
Ribavirin—SLC29A1—head—head and neck cancer	0.00105	0.0137	CbGeAlD
Ribavirin—NT5C2—Metabolism—UROD—head and neck cancer	0.000932	0.0122	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—UROD—head and neck cancer	0.000932	0.0122	CbGpPWpGaD
Ribavirin—ADK—lymph node—head and neck cancer	0.000861	0.0113	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000794	0.0104	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000792	0.0103	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—UROD—head and neck cancer	0.00076	0.00992	CbGpPWpGaD
Ribavirin—SLC29A1—lymph node—head and neck cancer	0.000733	0.00962	CbGeAlD
Ribavirin—ADK—Metabolism—UROD—head and neck cancer	0.000707	0.00922	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—AKT1—head and neck cancer	0.000699	0.00912	CbGpPWpGaD
Ribavirin—Inflammation—Docetaxel—head and neck cancer	0.000627	0.00308	CcSEcCtD
Ribavirin—Lethargy—Fluorouracil—head and neck cancer	0.000624	0.00307	CcSEcCtD
Ribavirin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00062	0.00304	CcSEcCtD
Ribavirin—Respiratory failure—Docetaxel—head and neck cancer	0.00062	0.00304	CcSEcCtD
Ribavirin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000612	0.003	CcSEcCtD
Ribavirin—Pulmonary embolism—Docetaxel—head and neck cancer	0.000608	0.00299	CcSEcCtD
Ribavirin—Injection site reaction—Docetaxel—head and neck cancer	0.000605	0.00297	CcSEcCtD
Ribavirin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000591	0.0029	CcSEcCtD
Ribavirin—Influenza like illness—Docetaxel—head and neck cancer	0.000591	0.0029	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000591	0.00771	CbGpPWpGaD
Ribavirin—Haemorrhage—Hydroxyurea—head and neck cancer	0.000588	0.00289	CcSEcCtD
Ribavirin—Hallucination—Hydroxyurea—head and neck cancer	0.000585	0.00287	CcSEcCtD
Ribavirin—Colitis—Docetaxel—head and neck cancer	0.000584	0.00287	CcSEcCtD
Ribavirin—Irritability—Fluorouracil—head and neck cancer	0.000584	0.00287	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—PTEN—head and neck cancer	0.000582	0.0076	CbGpPWpGaD
Ribavirin—Cardiac arrest—Fluorouracil—head and neck cancer	0.000582	0.00286	CcSEcCtD
Ribavirin—Candida infection—Docetaxel—head and neck cancer	0.000581	0.00285	CcSEcCtD
Ribavirin—Skin exfoliation—Docetaxel—head and neck cancer	0.000581	0.00285	CcSEcCtD
Ribavirin—Ataxia—Fluorouracil—head and neck cancer	0.000575	0.00283	CcSEcCtD
Ribavirin—Neuropathy—Docetaxel—head and neck cancer	0.000571	0.00281	CcSEcCtD
Ribavirin—Alopecia—Vinblastine—head and neck cancer	0.00057	0.0028	CcSEcCtD
Ribavirin—Dry skin—Fluorouracil—head and neck cancer	0.000561	0.00275	CcSEcCtD
Ribavirin—Neoplasm—Docetaxel—head and neck cancer	0.00055	0.0027	CcSEcCtD
Ribavirin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000547	0.00269	CcSEcCtD
Ribavirin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000542	0.00266	CcSEcCtD
Ribavirin—Muscular weakness—Fluorouracil—head and neck cancer	0.00054	0.00265	CcSEcCtD
Ribavirin—Angiopathy—Hydroxyurea—head and neck cancer	0.000534	0.00262	CcSEcCtD
Ribavirin—Sepsis—Docetaxel—head and neck cancer	0.000528	0.00259	CcSEcCtD
Ribavirin—Chills—Hydroxyurea—head and neck cancer	0.000528	0.00259	CcSEcCtD
Ribavirin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000521	0.00256	CcSEcCtD
Ribavirin—Alopecia—Hydroxyurea—head and neck cancer	0.00052	0.00255	CcSEcCtD
Ribavirin—Anaemia—Vinblastine—head and neck cancer	0.000519	0.00255	CcSEcCtD
Ribavirin—Angina pectoris—Fluorouracil—head and neck cancer	0.000515	0.00253	CcSEcCtD
Ribavirin—Erythema—Hydroxyurea—head and neck cancer	0.000512	0.00251	CcSEcCtD
Ribavirin—Malaise—Vinblastine—head and neck cancer	0.000506	0.00249	CcSEcCtD
Ribavirin—Vertigo—Vinblastine—head and neck cancer	0.000504	0.00248	CcSEcCtD
Ribavirin—Leukopenia—Vinblastine—head and neck cancer	0.000503	0.00247	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—MAPK3—head and neck cancer	0.000498	0.0065	CbGpPWpGaD
Ribavirin—Deafness—Docetaxel—head and neck cancer	0.000494	0.00242	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000492	0.00241	CcSEcCtD
Ribavirin—Hepatic failure—Docetaxel—head and neck cancer	0.000491	0.00241	CcSEcCtD
Ribavirin—Convulsion—Vinblastine—head and neck cancer	0.000486	0.00239	CcSEcCtD
Ribavirin—Hypertension—Vinblastine—head and neck cancer	0.000485	0.00238	CcSEcCtD
Ribavirin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000483	0.00237	CcSEcCtD
Ribavirin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000475	0.00233	CcSEcCtD
Ribavirin—Pneumonia—Fluorouracil—head and neck cancer	0.000474	0.00233	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—MAPK1—head and neck cancer	0.000474	0.00618	CbGpPWpGaD
Ribavirin—Anaemia—Hydroxyurea—head and neck cancer	0.000473	0.00232	CcSEcCtD
Ribavirin—Discomfort—Vinblastine—head and neck cancer	0.000472	0.00232	CcSEcCtD
Ribavirin—Infestation—Fluorouracil—head and neck cancer	0.000472	0.00232	CcSEcCtD
Ribavirin—Infestation NOS—Fluorouracil—head and neck cancer	0.000472	0.00232	CcSEcCtD
Ribavirin—Visual disturbance—Docetaxel—head and neck cancer	0.000466	0.00229	CcSEcCtD
Ribavirin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000465	0.00228	CcSEcCtD
Ribavirin—Renal impairment—Docetaxel—head and neck cancer	0.000464	0.00228	CcSEcCtD
Ribavirin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000462	0.00227	CcSEcCtD
Ribavirin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000462	0.00227	CcSEcCtD
Ribavirin—Malaise—Hydroxyurea—head and neck cancer	0.000462	0.00227	CcSEcCtD
Ribavirin—Stomatitis—Fluorouracil—head and neck cancer	0.00046	0.00226	CcSEcCtD
Ribavirin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000458	0.00225	CcSEcCtD
Ribavirin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000458	0.00225	CcSEcCtD
Ribavirin—Leukopenia—Hydroxyurea—head and neck cancer	0.000458	0.00225	CcSEcCtD
Ribavirin—Lethargy—Docetaxel—head and neck cancer	0.000451	0.00221	CcSEcCtD
Ribavirin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000449	0.0022	CcSEcCtD
Ribavirin—Epistaxis—Fluorouracil—head and neck cancer	0.000445	0.00218	CcSEcCtD
Ribavirin—Convulsion—Hydroxyurea—head and neck cancer	0.000444	0.00218	CcSEcCtD
Ribavirin—Sinusitis—Fluorouracil—head and neck cancer	0.000442	0.00217	CcSEcCtD
Ribavirin—Pain in extremity—Docetaxel—head and neck cancer	0.000442	0.00217	CcSEcCtD
Ribavirin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000442	0.00217	CcSEcCtD
Ribavirin—Anorexia—Vinblastine—head and neck cancer	0.000437	0.00214	CcSEcCtD
Ribavirin—Migraine—Docetaxel—head and neck cancer	0.000435	0.00213	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000433	0.00213	CcSEcCtD
Ribavirin—Discomfort—Hydroxyurea—head and neck cancer	0.000431	0.00211	CcSEcCtD
Ribavirin—Haemoglobin—Fluorouracil—head and neck cancer	0.000425	0.00209	CcSEcCtD
Ribavirin—Rhinitis—Fluorouracil—head and neck cancer	0.000424	0.00208	CcSEcCtD
Ribavirin—Haemorrhage—Fluorouracil—head and neck cancer	0.000423	0.00208	CcSEcCtD
Ribavirin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000421	0.00207	CcSEcCtD
Ribavirin—Pharyngitis—Fluorouracil—head and neck cancer	0.00042	0.00206	CcSEcCtD
Ribavirin—Oedema—Hydroxyurea—head and neck cancer	0.000418	0.00205	CcSEcCtD
Ribavirin—Ataxia—Docetaxel—head and neck cancer	0.000415	0.00204	CcSEcCtD
Ribavirin—Paraesthesia—Vinblastine—head and neck cancer	0.000411	0.00202	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—PIK3CA—head and neck cancer	0.000411	0.00536	CbGpPWpGaD
Ribavirin—Dehydration—Docetaxel—head and neck cancer	0.000411	0.00202	CcSEcCtD
Ribavirin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00041	0.00201	CcSEcCtD
Ribavirin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000409	0.00201	CcSEcCtD
Ribavirin—Skin disorder—Hydroxyurea—head and neck cancer	0.000406	0.00199	CcSEcCtD
Ribavirin—Dry skin—Docetaxel—head and neck cancer	0.000405	0.00199	CcSEcCtD
Ribavirin—Abdominal pain upper—Docetaxel—head and neck cancer	0.000403	0.00198	CcSEcCtD
Ribavirin—Breast disorder—Docetaxel—head and neck cancer	0.000399	0.00196	CcSEcCtD
Ribavirin—Anorexia—Hydroxyurea—head and neck cancer	0.000398	0.00196	CcSEcCtD
Ribavirin—Decreased appetite—Vinblastine—head and neck cancer	0.000398	0.00196	CcSEcCtD
Ribavirin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000398	0.00195	CcSEcCtD
Ribavirin—Nasopharyngitis—Docetaxel—head and neck cancer	0.000395	0.00194	CcSEcCtD
Ribavirin—Constipation—Vinblastine—head and neck cancer	0.000392	0.00192	CcSEcCtD
Ribavirin—Pain—Vinblastine—head and neck cancer	0.000392	0.00192	CcSEcCtD
Ribavirin—ENPP1—Metabolism—NAT2—head and neck cancer	0.000387	0.00505	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NAT2—head and neck cancer	0.000387	0.00505	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—HRAS—head and neck cancer	0.00038	0.00496	CbGpPWpGaD
Ribavirin—Arrhythmia—Fluorouracil—head and neck cancer	0.000378	0.00186	CcSEcCtD
Ribavirin—Feeling abnormal—Vinblastine—head and neck cancer	0.000378	0.00185	CcSEcCtD
Ribavirin—Bronchospasm—Docetaxel—head and neck cancer	0.000375	0.00184	CcSEcCtD
Ribavirin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000375	0.00184	CcSEcCtD
Ribavirin—Alopecia—Fluorouracil—head and neck cancer	0.000374	0.00184	CcSEcCtD
Ribavirin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000373	0.00183	CcSEcCtD
Ribavirin—Angina pectoris—Docetaxel—head and neck cancer	0.000372	0.00183	CcSEcCtD
Ribavirin—Somnolence—Hydroxyurea—head and neck cancer	0.000371	0.00182	CcSEcCtD
Ribavirin—Erythema—Fluorouracil—head and neck cancer	0.000369	0.00181	CcSEcCtD
Ribavirin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000368	0.00181	CcSEcCtD
Ribavirin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000363	0.00178	CcSEcCtD
Ribavirin—Abdominal pain—Vinblastine—head and neck cancer	0.000362	0.00178	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000361	0.00177	CcSEcCtD
Ribavirin—Fatigue—Hydroxyurea—head and neck cancer	0.00036	0.00177	CcSEcCtD
Ribavirin—Pain—Hydroxyurea—head and neck cancer	0.000357	0.00175	CcSEcCtD
Ribavirin—Constipation—Hydroxyurea—head and neck cancer	0.000357	0.00175	CcSEcCtD
Ribavirin—Neutropenia—Docetaxel—head and neck cancer	0.000357	0.00175	CcSEcCtD
Ribavirin—Weight increased—Docetaxel—head and neck cancer	0.000347	0.00171	CcSEcCtD
Ribavirin—Vision blurred—Fluorouracil—head and neck cancer	0.000347	0.00171	CcSEcCtD
Ribavirin—Weight decreased—Docetaxel—head and neck cancer	0.000345	0.0017	CcSEcCtD
Ribavirin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000344	0.00169	CcSEcCtD
Ribavirin—Pneumonia—Docetaxel—head and neck cancer	0.000342	0.00168	CcSEcCtD
Ribavirin—Anaemia—Fluorouracil—head and neck cancer	0.000341	0.00167	CcSEcCtD
Ribavirin—Infestation—Docetaxel—head and neck cancer	0.00034	0.00167	CcSEcCtD
Ribavirin—Infestation NOS—Docetaxel—head and neck cancer	0.00034	0.00167	CcSEcCtD
Ribavirin—NT5C2—Metabolism—DPYD—head and neck cancer	0.000339	0.00443	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—DPYD—head and neck cancer	0.000339	0.00443	CbGpPWpGaD
Ribavirin—Hypersensitivity—Vinblastine—head and neck cancer	0.000338	0.00166	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000337	0.00166	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—AKT1—head and neck cancer	0.000336	0.00438	CbGpPWpGaD
Ribavirin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000336	0.00165	CcSEcCtD
Ribavirin—Renal failure—Docetaxel—head and neck cancer	0.000335	0.00164	CcSEcCtD
Ribavirin—Myocardial infarction—Docetaxel—head and neck cancer	0.000334	0.00164	CcSEcCtD
Ribavirin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000334	0.00164	CcSEcCtD
Ribavirin—Stomatitis—Docetaxel—head and neck cancer	0.000332	0.00163	CcSEcCtD
Ribavirin—Jaundice—Docetaxel—head and neck cancer	0.000332	0.00163	CcSEcCtD
Ribavirin—Conjunctivitis—Docetaxel—head and neck cancer	0.000331	0.00162	CcSEcCtD
Ribavirin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00033	0.00162	CcSEcCtD
Ribavirin—Leukopenia—Fluorouracil—head and neck cancer	0.00033	0.00162	CcSEcCtD
Ribavirin—Asthenia—Vinblastine—head and neck cancer	0.000329	0.00161	CcSEcCtD
Ribavirin—NT5C2—Metabolism—YAP1—head and neck cancer	0.000322	0.00421	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—YAP1—head and neck cancer	0.000322	0.00421	CbGpPWpGaD
Ribavirin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000322	0.00158	CcSEcCtD
Ribavirin—Epistaxis—Docetaxel—head and neck cancer	0.000321	0.00158	CcSEcCtD
Ribavirin—Convulsion—Fluorouracil—head and neck cancer	0.000319	0.00157	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—NAT2—head and neck cancer	0.000316	0.00412	CbGpPWpGaD
Ribavirin—Chest pain—Fluorouracil—head and neck cancer	0.000314	0.00154	CcSEcCtD
Ribavirin—Myalgia—Fluorouracil—head and neck cancer	0.000314	0.00154	CcSEcCtD
Ribavirin—Diarrhoea—Vinblastine—head and neck cancer	0.000313	0.00154	CcSEcCtD
Ribavirin—Discomfort—Fluorouracil—head and neck cancer	0.00031	0.00152	CcSEcCtD
Ribavirin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000308	0.00151	CcSEcCtD
Ribavirin—Haemoglobin—Docetaxel—head and neck cancer	0.000307	0.00151	CcSEcCtD
Ribavirin—Rhinitis—Docetaxel—head and neck cancer	0.000306	0.0015	CcSEcCtD
Ribavirin—Haemorrhage—Docetaxel—head and neck cancer	0.000306	0.0015	CcSEcCtD
Ribavirin—Hepatitis—Docetaxel—head and neck cancer	0.000306	0.0015	CcSEcCtD
Ribavirin—Hypoaesthesia—Docetaxel—head and neck cancer	0.000304	0.00149	CcSEcCtD
Ribavirin—Confusional state—Fluorouracil—head and neck cancer	0.000303	0.00149	CcSEcCtD
Ribavirin—Pharyngitis—Docetaxel—head and neck cancer	0.000303	0.00149	CcSEcCtD
Ribavirin—Dizziness—Vinblastine—head and neck cancer	0.000303	0.00149	CcSEcCtD
Ribavirin—Urinary tract disorder—Docetaxel—head and neck cancer	0.000302	0.00148	CcSEcCtD
Ribavirin—Oedema peripheral—Docetaxel—head and neck cancer	0.000301	0.00148	CcSEcCtD
Ribavirin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000301	0.00148	CcSEcCtD
Ribavirin—Oedema—Fluorouracil—head and neck cancer	0.000301	0.00148	CcSEcCtD
Ribavirin—Connective tissue disorder—Docetaxel—head and neck cancer	0.0003	0.00147	CcSEcCtD
Ribavirin—Asthenia—Hydroxyurea—head and neck cancer	0.0003	0.00147	CcSEcCtD
Ribavirin—Urethral disorder—Docetaxel—head and neck cancer	0.0003	0.00147	CcSEcCtD
Ribavirin—Nervous system disorder—Fluorouracil—head and neck cancer	0.000295	0.00145	CcSEcCtD
Ribavirin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000294	0.00145	CcSEcCtD
Ribavirin—Visual impairment—Docetaxel—head and neck cancer	0.000294	0.00145	CcSEcCtD
Ribavirin—Tachycardia—Fluorouracil—head and neck cancer	0.000294	0.00144	CcSEcCtD
Ribavirin—ADK—Metabolism—NAT2—head and neck cancer	0.000293	0.00383	CbGpPWpGaD
Ribavirin—Vomiting—Vinblastine—head and neck cancer	0.000291	0.00143	CcSEcCtD
Ribavirin—Erythema multiforme—Docetaxel—head and neck cancer	0.000289	0.00142	CcSEcCtD
Ribavirin—Headache—Vinblastine—head and neck cancer	0.000287	0.00141	CcSEcCtD
Ribavirin—Anorexia—Fluorouracil—head and neck cancer	0.000287	0.00141	CcSEcCtD
Ribavirin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000286	0.0014	CcSEcCtD
Ribavirin—Eye disorder—Docetaxel—head and neck cancer	0.000286	0.0014	CcSEcCtD
Ribavirin—Flushing—Docetaxel—head and neck cancer	0.000284	0.00139	CcSEcCtD
Ribavirin—Cardiac disorder—Docetaxel—head and neck cancer	0.000284	0.00139	CcSEcCtD
Ribavirin—Hypotension—Fluorouracil—head and neck cancer	0.000281	0.00138	CcSEcCtD
Ribavirin—Angiopathy—Docetaxel—head and neck cancer	0.000277	0.00136	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—DPYD—head and neck cancer	0.000277	0.00361	CbGpPWpGaD
Ribavirin—Dizziness—Hydroxyurea—head and neck cancer	0.000276	0.00136	CcSEcCtD
Ribavirin—Immune system disorder—Docetaxel—head and neck cancer	0.000276	0.00136	CcSEcCtD
Ribavirin—Mediastinal disorder—Docetaxel—head and neck cancer	0.000275	0.00135	CcSEcCtD
Ribavirin—Chills—Docetaxel—head and neck cancer	0.000274	0.00135	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000274	0.00135	CcSEcCtD
Ribavirin—Arrhythmia—Docetaxel—head and neck cancer	0.000273	0.00134	CcSEcCtD
Ribavirin—Nausea—Vinblastine—head and neck cancer	0.000272	0.00134	CcSEcCtD
Ribavirin—Insomnia—Fluorouracil—head and neck cancer	0.000272	0.00134	CcSEcCtD
Ribavirin—Paraesthesia—Fluorouracil—head and neck cancer	0.00027	0.00133	CcSEcCtD
Ribavirin—Alopecia—Docetaxel—head and neck cancer	0.00027	0.00133	CcSEcCtD
Ribavirin—Dyspnoea—Fluorouracil—head and neck cancer	0.000268	0.00132	CcSEcCtD
Ribavirin—Mental disorder—Docetaxel—head and neck cancer	0.000268	0.00131	CcSEcCtD
Ribavirin—Somnolence—Fluorouracil—head and neck cancer	0.000267	0.00131	CcSEcCtD
Ribavirin—Malnutrition—Docetaxel—head and neck cancer	0.000266	0.00131	CcSEcCtD
Ribavirin—Erythema—Docetaxel—head and neck cancer	0.000266	0.00131	CcSEcCtD
Ribavirin—Vomiting—Hydroxyurea—head and neck cancer	0.000266	0.0013	CcSEcCtD
Ribavirin—Dyspepsia—Fluorouracil—head and neck cancer	0.000265	0.0013	CcSEcCtD
Ribavirin—Rash—Hydroxyurea—head and neck cancer	0.000263	0.00129	CcSEcCtD
Ribavirin—Dermatitis—Hydroxyurea—head and neck cancer	0.000263	0.00129	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—YAP1—head and neck cancer	0.000263	0.00343	CbGpPWpGaD
Ribavirin—Headache—Hydroxyurea—head and neck cancer	0.000262	0.00129	CcSEcCtD
Ribavirin—Decreased appetite—Fluorouracil—head and neck cancer	0.000261	0.00128	CcSEcCtD
Ribavirin—Dysgeusia—Docetaxel—head and neck cancer	0.00026	0.00128	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00026	0.00127	CcSEcCtD
Ribavirin—Back pain—Docetaxel—head and neck cancer	0.000257	0.00126	CcSEcCtD
Ribavirin—ADK—Metabolism—DPYD—head and neck cancer	0.000257	0.00336	CbGpPWpGaD
Ribavirin—Pain—Fluorouracil—head and neck cancer	0.000257	0.00126	CcSEcCtD
Ribavirin—Muscle spasms—Docetaxel—head and neck cancer	0.000256	0.00126	CcSEcCtD
Ribavirin—Nausea—Hydroxyurea—head and neck cancer	0.000248	0.00122	CcSEcCtD
Ribavirin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000248	0.00122	CcSEcCtD
Ribavirin—Anaemia—Docetaxel—head and neck cancer	0.000246	0.00121	CcSEcCtD
Ribavirin—ADK—Metabolism—YAP1—head and neck cancer	0.000244	0.00319	CbGpPWpGaD
Ribavirin—Urticaria—Fluorouracil—head and neck cancer	0.000239	0.00117	CcSEcCtD
Ribavirin—Syncope—Docetaxel—head and neck cancer	0.000239	0.00117	CcSEcCtD
Ribavirin—Leukopenia—Docetaxel—head and neck cancer	0.000238	0.00117	CcSEcCtD
Ribavirin—Body temperature increased—Fluorouracil—head and neck cancer	0.000238	0.00117	CcSEcCtD
Ribavirin—Palpitations—Docetaxel—head and neck cancer	0.000235	0.00115	CcSEcCtD
Ribavirin—Loss of consciousness—Docetaxel—head and neck cancer	0.000234	0.00115	CcSEcCtD
Ribavirin—Cough—Docetaxel—head and neck cancer	0.000232	0.00114	CcSEcCtD
Ribavirin—Convulsion—Docetaxel—head and neck cancer	0.00023	0.00113	CcSEcCtD
Ribavirin—Hypertension—Docetaxel—head and neck cancer	0.00023	0.00113	CcSEcCtD
Ribavirin—Myalgia—Docetaxel—head and neck cancer	0.000226	0.00111	CcSEcCtD
Ribavirin—Arthralgia—Docetaxel—head and neck cancer	0.000226	0.00111	CcSEcCtD
Ribavirin—Chest pain—Docetaxel—head and neck cancer	0.000226	0.00111	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000225	0.0011	CcSEcCtD
Ribavirin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000222	0.00109	CcSEcCtD
Ribavirin—Dry mouth—Docetaxel—head and neck cancer	0.000221	0.00109	CcSEcCtD
Ribavirin—Confusional state—Docetaxel—head and neck cancer	0.000219	0.00107	CcSEcCtD
Ribavirin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000217	0.00107	CcSEcCtD
Ribavirin—Oedema—Docetaxel—head and neck cancer	0.000217	0.00107	CcSEcCtD
Ribavirin—Shock—Docetaxel—head and neck cancer	0.000214	0.00105	CcSEcCtD
Ribavirin—Nervous system disorder—Docetaxel—head and neck cancer	0.000213	0.00105	CcSEcCtD
Ribavirin—Pruritus—Fluorouracil—head and neck cancer	0.000213	0.00104	CcSEcCtD
Ribavirin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000213	0.00104	CcSEcCtD
Ribavirin—Tachycardia—Docetaxel—head and neck cancer	0.000212	0.00104	CcSEcCtD
Ribavirin—Skin disorder—Docetaxel—head and neck cancer	0.000211	0.00104	CcSEcCtD
Ribavirin—Anorexia—Docetaxel—head and neck cancer	0.000207	0.00102	CcSEcCtD
Ribavirin—Diarrhoea—Fluorouracil—head and neck cancer	0.000206	0.00101	CcSEcCtD
Ribavirin—Hypotension—Docetaxel—head and neck cancer	0.000203	0.000996	CcSEcCtD
Ribavirin—Dizziness—Fluorouracil—head and neck cancer	0.000199	0.000977	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000198	0.000971	CcSEcCtD
Ribavirin—Insomnia—Docetaxel—head and neck cancer	0.000196	0.000964	CcSEcCtD
Ribavirin—Paraesthesia—Docetaxel—head and neck cancer	0.000195	0.000957	CcSEcCtD
Ribavirin—Dyspnoea—Docetaxel—head and neck cancer	0.000194	0.00095	CcSEcCtD
Ribavirin—ENPP1—Metabolism—TYMS—head and neck cancer	0.000193	0.00253	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TYMS—head and neck cancer	0.000193	0.00253	CbGpPWpGaD
Ribavirin—Somnolence—Docetaxel—head and neck cancer	0.000193	0.000948	CcSEcCtD
Ribavirin—Vomiting—Fluorouracil—head and neck cancer	0.000191	0.000939	CcSEcCtD
Ribavirin—ENPP1—Metabolism—GSTM1—head and neck cancer	0.000191	0.0025	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTM1—head and neck cancer	0.000191	0.0025	CbGpPWpGaD
Ribavirin—Dyspepsia—Docetaxel—head and neck cancer	0.000191	0.000938	CcSEcCtD
Ribavirin—Rash—Fluorouracil—head and neck cancer	0.00019	0.000931	CcSEcCtD
Ribavirin—Dermatitis—Fluorouracil—head and neck cancer	0.000189	0.00093	CcSEcCtD
Ribavirin—Decreased appetite—Docetaxel—head and neck cancer	0.000189	0.000927	CcSEcCtD
Ribavirin—Headache—Fluorouracil—head and neck cancer	0.000188	0.000925	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000187	0.00092	CcSEcCtD
Ribavirin—Fatigue—Docetaxel—head and neck cancer	0.000187	0.000919	CcSEcCtD
Ribavirin—Pain—Docetaxel—head and neck cancer	0.000186	0.000912	CcSEcCtD
Ribavirin—Constipation—Docetaxel—head and neck cancer	0.000186	0.000912	CcSEcCtD
Ribavirin—NT5C2—Metabolism—GPX1—head and neck cancer	0.000183	0.00239	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GPX1—head and neck cancer	0.000183	0.00239	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP1A1—head and neck cancer	0.000181	0.00237	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP1A1—head and neck cancer	0.000181	0.00237	CbGpPWpGaD
Ribavirin—Feeling abnormal—Docetaxel—head and neck cancer	0.000179	0.000878	CcSEcCtD
Ribavirin—Nausea—Fluorouracil—head and neck cancer	0.000179	0.000877	CcSEcCtD
Ribavirin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000178	0.000872	CcSEcCtD
Ribavirin—ENPP1—Disease—NOTCH1—head and neck cancer	0.000173	0.00226	CbGpPWpGaD
Ribavirin—Abdominal pain—Docetaxel—head and neck cancer	0.000172	0.000843	CcSEcCtD
Ribavirin—Body temperature increased—Docetaxel—head and neck cancer	0.000172	0.000843	CcSEcCtD
Ribavirin—Hypersensitivity—Docetaxel—head and neck cancer	0.00016	0.000785	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—TYMS—head and neck cancer	0.000158	0.00206	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTM1—head and neck cancer	0.000156	0.00204	CbGpPWpGaD
Ribavirin—Asthenia—Docetaxel—head and neck cancer	0.000156	0.000765	CcSEcCtD
Ribavirin—Pruritus—Docetaxel—head and neck cancer	0.000154	0.000754	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—GPX1—head and neck cancer	0.000149	0.00195	CbGpPWpGaD
Ribavirin—Diarrhoea—Docetaxel—head and neck cancer	0.000149	0.000729	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CYP1A1—head and neck cancer	0.000148	0.00193	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TYMS—head and neck cancer	0.000147	0.00191	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTM1—head and neck cancer	0.000145	0.00189	CbGpPWpGaD
Ribavirin—Dizziness—Docetaxel—head and neck cancer	0.000144	0.000705	CcSEcCtD
Ribavirin—ADK—Metabolism—GPX1—head and neck cancer	0.000139	0.00181	CbGpPWpGaD
Ribavirin—Vomiting—Docetaxel—head and neck cancer	0.000138	0.000678	CcSEcCtD
Ribavirin—ADK—Metabolism—CYP1A1—head and neck cancer	0.000137	0.00179	CbGpPWpGaD
Ribavirin—Rash—Docetaxel—head and neck cancer	0.000137	0.000672	CcSEcCtD
Ribavirin—Dermatitis—Docetaxel—head and neck cancer	0.000137	0.000671	CcSEcCtD
Ribavirin—Headache—Docetaxel—head and neck cancer	0.000136	0.000668	CcSEcCtD
Ribavirin—Nausea—Docetaxel—head and neck cancer	0.000129	0.000633	CcSEcCtD
Ribavirin—ENPP1—Disease—PTGS2—head and neck cancer	0.000129	0.00168	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTEN—head and neck cancer	0.000112	0.00147	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTGS2—head and neck cancer	0.000108	0.00141	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTGS2—head and neck cancer	0.000108	0.00141	CbGpPWpGaD
Ribavirin—ENPP1—Disease—STAT3—head and neck cancer	0.0001	0.00131	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MAPK3—head and neck cancer	9.59e-05	0.00125	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTEN—head and neck cancer	9.4e-05	0.00123	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTEN—head and neck cancer	9.4e-05	0.00123	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MAPK1—head and neck cancer	9.13e-05	0.00119	CbGpPWpGaD
Ribavirin—ENPP1—Disease—EGFR—head and neck cancer	9.12e-05	0.00119	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTGS2—head and neck cancer	8.79e-05	0.00115	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTGS2—head and neck cancer	8.17e-05	0.00107	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3CA—head and neck cancer	7.92e-05	0.00103	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTEN—head and neck cancer	7.66e-05	0.001	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HRAS—head and neck cancer	7.33e-05	0.000957	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTEN—head and neck cancer	7.12e-05	0.00093	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CA—head and neck cancer	6.63e-05	0.000866	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CA—head and neck cancer	6.63e-05	0.000866	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKT1—head and neck cancer	6.47e-05	0.000845	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AKT1—head and neck cancer	5.42e-05	0.000707	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKT1—head and neck cancer	5.42e-05	0.000707	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CA—head and neck cancer	5.41e-05	0.000706	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3CA—head and neck cancer	5.03e-05	0.000656	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKT1—head and neck cancer	4.42e-05	0.000577	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKT1—head and neck cancer	4.11e-05	0.000536	CbGpPWpGaD
